| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 189.45B | 185.15B | 202.52B | 180.32B | 294.67B | 185.79B |
| Gross Profit | 29.56B | 32.76B | 41.15B | 41.73B | 71.05B | 66.09B |
| EBITDA | 22.09B | 27.80B | 42.56B | 37.73B | 64.40B | 59.89B |
| Net Income | 14.56B | 15.64B | 25.61B | 23.26B | 40.16B | 43.90B |
Balance Sheet | ||||||
| Total Assets | 901.56B | 908.63B | 923.60B | 1.03T | 1.06T | 976.56B |
| Cash, Cash Equivalents and Short-Term Investments | 108.96B | 124.17B | 105.63B | 123.85B | 160.19B | 130.98B |
| Total Debt | 228.41B | 242.55B | 258.72B | 317.04B | 308.49B | 213.67B |
| Total Liabilities | 483.81B | 506.80B | 530.69B | 606.45B | 627.29B | 587.26B |
| Stockholders Equity | 386.62B | 380.61B | 373.02B | 397.99B | 420.27B | 372.46B |
Cash Flow | ||||||
| Free Cash Flow | 42.78B | 46.26B | 35.07B | -12.64B | 16.70B | 5.53B |
| Operating Cash Flow | 41.10B | 46.45B | 35.28B | -11.90B | 16.97B | 5.88B |
| Investing Cash Flow | 6.20B | 1.84B | -4.77B | -8.14B | -14.47B | -4.04B |
| Financing Cash Flow | -39.54B | -29.80B | -35.02B | -2.07B | 14.43B | 8.04B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$379.61B | 6.70 | 3.55% | 3.89% | 9.45% | 1.21% | |
70 Outperform | HK$158.75B | 12.36 | 2.75% | 4.33% | 9.72% | -26.47% | |
67 Neutral | HK$109.55B | 15.34 | 2.41% | 5.62% | -0.48% | -13.78% | |
66 Neutral | HK$204.80B | 3.72 | 9.47% | 5.18% | 14.40% | -2.55% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
62 Neutral | HK$52.32B | 52.44 | 0.65% | 3.96% | -16.02% | -30.04% | |
59 Neutral | HK$127.73B | 4.03 | 3.80% | 4.54% | -9.54% | -38.16% |